pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
VABYSMO · news · pharmadog
← back to VABYSMO
News mentioning VABYSMO
13
stories
3d
This week in charts: Kodiak’s big comeback and Hengrui’s dealmaking
biopharma dive
7d
Kodiak skyrockets on positive study data for 2 eye drugs
biopharma dive
10d
Genentech makes $1.5B+ deal with AI heavyweight Earendil for cancer bispecifics
biospace
11d
Merck sees pivotal victory for $3B eye disease prospect
fiercebiotech
18d
Roche bets up to $1B to advance next-gen bispecifics with Dualitas
biospace
18d
Roche, Dualitas team up to find bispecific drugs for immune diseases
biopharma dive
18d
Roche signs $1B deal with Dualitas to pair up on big bispecific screening drive
fiercebiotech
Aug 17, 26
EyePoint plummets on pivotal data for main drug
biopharma dive
Jul 27, 26
FDA scientists question Capricor data; Legend CEO steps down
biopharma dive
Jul 23, 26
Roche's late stage pipeline 'so full,' CEO Schinecker not feeling pressure to add on
biospace
Jul 23, 26
Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies
fiercebiotech
Jun 30, 26
These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.
biopharma dive
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: TriGemX tacks on $94M; AnaCardio adds $71M
fiercebiotech
